NPC1L1 and Hypercholesterolemia: By specifically blocking the NPC1L1 protein at the jejunal brush barrier [3], NPC1L1 inhibitors prevent intestinal cholesterol absorption and offer a vital adjunctive method for treating hypercholesterolemia [4].